NeoPharm CO. LTD

NeoPharm CO. LTD

092730 · KQ · Consumer Non-Cyclicals / Personal & Household Products & Services

21,600.00KRW-700.00 (-3.14%)

Price History

Full chart

Market Stats

Previous Close22,300.00
Open22,300.00
Day Range21,550.00 – 22,300.00
52-Week Range15,590.00 – 26,000.00
Volume41.72K
Market Cap360.53B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield3.51%
Beta0.93
50-Day Avg22,384.60
200-Day Avg19,445.45

About

NeoPharm CO., LTD. manufactures and sells skin care products in South Korea. The company offers Atopalm, a non-steroid product for sensitive and dry skin; skin dermo-cosmetic products under the Real Barrier brand; products for sensitive, dry, oily, or trouble-prone skin under the ZEROID brand; body moisturizers under the Derma-B brand; and sport care products for athletes under the MISSION ATHELETCARE brand. NeoPharm CO., LTD. was founded in 2000 and is headquartered in Daejeon, South Korea.

Company Details

  • SectorConsumer Non-Cyclicals
  • IndustryPersonal & Household Products & Services
  • CEOByeong-Deog Park
  • Employees141
  • Headquarters309-8, Techno 2-ro, Daejeon, South Korea, Korea
  • Websitehttps://www.neopharm.co.kr

Leadership

  • Byeong-Deog ParkChief Exec. Officer and Pres · b. 1966

Financials

Income Statement

Currency: KRW2012-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue18.77B35.96B42.37B53.63B66.27B83.24B81.63B87.93B85.03B97.10B119.01B132.18B
Growth (%)-+91.56%+17.81%+26.59%+23.57%+25.60%-1.94%+7.72%-3.30%+14.20%+22.56%+11.07%
Cost of Revenue4.69B9.40B10.49B13.49B17.94B23.14B22.98B25.54B26.65B31.72B44.99B45.79B
Gross Profit14.09B26.57B31.88B40.14B48.34B60.10B58.64B62.39B58.38B65.39B74.03B86.40B
Gross Margin75.03%73.88%75.24%74.85%72.93%72.21%71.84%70.95%68.66%67.33%62.20%65.36%
Operating Expense14.21B22.02B22.31B26.07B29.16B37.39B36.74B39.97B36.95B40.09B49.38B57.62B
Operating Income-121.87M4.55B9.56B14.08B19.18B22.71B21.90B22.42B21.43B25.29B24.65B28.77B
Operating Margin-0.65%12.64%22.57%26.25%28.94%27.29%26.83%25.50%25.20%26.05%20.71%21.77%
EBITDA--------24.95B31.07B33.40B35.46B
EBITDA Margin--------29.34%31.99%28.06%26.82%
Net Income647.76M3.41B7.74B11.56B15.37B19.25B18.13B17.71B17.03B23.21B23.06B27.82B
Net Income Margin3.45%9.47%18.27%21.55%23.19%23.12%22.21%20.14%20.02%23.90%19.38%21.05%
R&D1.97B1.97B2.18B2.10B2.58B2.52B2.80B2.94B2.85B2.65B3.41B3.33B
R&D as % of Total Revenue10.51%5.49%5.15%3.91%3.89%3.03%3.43%3.34%3.36%2.73%2.86%2.52%
Interest Expense00000056.37M38.46M8.84M21.32M40.78M39.42M
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%0.07%0.04%0.01%0.02%0.03%0.03%

Balance Sheet

Currency: KRW2012-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets34.14B40.41B46.51B56.69B72.93B122.74B132.98B143.41B155.35B177.46B192.44B217.81B
Total Liabilities4.22B7.79B7.94B9.11B13.64B17.05B15.26B13.10B13.14B17.43B15.56B22.45B
Total Equity29.92B32.62B38.57B47.58B59.29B105.69B117.72B130.30B142.21B160.03B176.88B195.36B
Cash1.68B7.27B6.84B3.25B6.84B4.10B9.20B7.05B10.88B11.88B18.23B26.82B
Total Debt----430.94M4.40B4.02B-----

Cash Flow

Currency: KRW2012-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow564.34M6.09B9.16B10.65B16.18B19.22B17.07B21.68B18.16B23.26B18.63B28.41B
Investing Cash Flow-1.02B-2.68B-7.93B-11.31B-8.87B-53.21B-4.74B-16.69B-8.80B-16.35B-6.22B-
Financing Cash Flow-514.29M-2.10B-1.77B-2.50B-3.16B31.05B-6.57B-9.52B-5.75B-5.92B-6.50B-
Capital Expenditure172.47M786.89M1.40B884.71M1.94B5.90B285.62M320.11M806.43M20.83B3.08B1.42B
Free Cash Flow-----22.31B16.34B21.20B17.35B2.43B15.55B26.99B
Dividends Paid555.68M1.77B1.77B2.48B3.54B4.60B5.87B5.08B5.47B5.47B5.87B9.38B
FCF to OCF-----116.03%95.72%97.79%95.56%10.47%83.48%95.00%
Dividend Paid to FCF-----20.62%35.89%23.97%31.55%224.85%37.71%34.77%

Earnings

Report DateMar 31, 2009Jun 30, 2009Sep 30, 2009Dec 31, 2009Mar 31, 2010Jun 30, 2010Sep 30, 2010Dec 31, 2010Mar 31, 2011Jun 30, 2011Sep 30, 2011Dec 31, 2011Mar 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013Mar 31, 2014Jun 30, 2014Nov 14, 2014Feb 13, 2015May 4, 2015Aug 13, 2015Oct 30, 2015Jan 28, 2016Apr 26, 2016Aug 8, 2016Nov 8, 2016Feb 5, 2017Apr 26, 2017Aug 2, 2017Nov 7, 2017Feb 7, 2018May 2, 2018Aug 2, 2018Nov 2, 2018Feb 7, 2019May 3, 2019Aug 2, 2019Nov 8, 2019Feb 7, 2020May 8, 2020Aug 7, 2020Nov 6, 2020Feb 8, 2021May 7, 2021Aug 6, 2021Nov 5, 2021Feb 8, 2022May 13, 2022Aug 5, 2022Nov 4, 2022Feb 7, 2023May 12, 2023Aug 11, 2023Nov 10, 2023Mar 18, 2024May 10, 2024Aug 9, 2024Nov 8, 2024Mar 17, 2025May 9, 2025Aug 11, 2025Nov 11, 2025Dec 31, 2025May 7, 2026Jun 30, 2026
EPS Estimate-------------------------------369.00443.72230.12-323.00647.00---700.81517.82483.81771.22633.68614.72507.88372.26693.19--693.19657.00600.00466.00576.00--466.00466.00466.00---------
EPS Actual147.5333.35-4.00-18.7074.00-44.11-15.5070.4459.5629.92-2.72-31.5890.3815.16-65.203.3861.6577.12-42.9632.5087.8458.79-1.8268.37273.36117.33179.30-88.38423.91251.10253.18166.00474.00431.00318.43394.00602.00509.00396.00643.00662.00618.00527.00745.00689.00576.00374.00663.00726.00529.00397.00606.30630.00588.00509.00495.78870.59699.34509.00509.00509.00752.18277.20430.56456.28451.81438.54432.19551.37537.37
Surprise--------------------------------55.01%6.82%87.29%-21.98%-6.96%----5.54%19.35%8.93%-3.40%8.73%-6.30%-26.36%78.10%4.73%---12.53%-4.11%-2.00%9.23%-13.93%--9.23%9.23%9.23%---------
Timing----------------------Pre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketAfter-hoursPre-marketAfter-hoursPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketPre-market-Pre-market-

Key Statistics & Ratios

Market Cap360.53B
Enterprise Value226.11B
Trailing P/E0.00
Forward P/E0.00
Price / Sales2.80
Price / Book1.84
Revenue (TTM)86.80B
Gross Profit (TTM)62.39B
EBITDA23.20B
Profit Margin21.02%
Operating Margin24.88%
Return on Equity1438.68%
Return on Assets9.30%
Shares Outstanding7.99M
Shares Float4.62M
Beta0.93
Dividend Yield3.51%
Dividend Rate0.00
Payout Ratio38.28%

Dividends

20251×
750.00Dec 29, 2025
20241×
600.00Dec 27, 2024
20231×
375.00Dec 27, 2023
20221×
350.00Dec 28, 2022
20211×
350.00Dec 29, 2021
20201×
325.00Dec 29, 2020
20191×
375.00Dec 27, 2019
20181×
325.00Dec 27, 2018
20171×
250.00Dec 27, 2017
20161×
175.00Dec 28, 2016
20151×
125.00Dec 29, 2015
20141×
125.00Dec 29, 2014
20131×
50.00Dec 27, 2013
20121×
37.50Dec 27, 2012
20111×
37.50Dec 28, 2011
20101×
25.00Dec 29, 2010
20091×
40.00Dec 29, 2009
20081×
62.50Dec 29, 2008
20072×
19.23Dec 27, 200757.69Jun 28, 2007

Stock Splits

  • Oct 30, 20242:1
  • Jun 12, 200813:10